Mechanotransduction in cardiac hypertrophy and failure

Circulation Research

Volumn 116, Issue 8, 2015, Pages 1462-1476

  Lyon, Robert C ^a   Zanella, Fabian ^a   Omens, Jeffrey H ^a,b   Sheikh, Farah ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytoskeleton; Heart; Heart failure; Intercellular junctions; Mechanotransduction, cellular; Myocardium; Sarcolemma; Sarcomeres

Indexed keywords

CAVEOLIN 3; CONNECTIN; DYSTROGLYCAN; INTEGRIN; PROTEIN KINASE C; TALIN; THIOREDOXIN; VINCULIN; MULTIPROTEIN COMPLEX; MUSCLE PROTEIN;

CELL JUNCTION; CYTOSKELETON; DESMOSOME; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; MECHANOTRANSDUCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SARCOLEMMA; SARCOMERE; ADAPTATION; ANIMAL; CARDIAC MUSCLE CELL; CARDIOMEGALY; GENETICS; HEMODYNAMICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CARDIOMEGALY; HEART FAILURE; HEMODYNAMICS; HUMANS; MECHANOTRANSDUCTION, CELLULAR; MULTIPROTEIN COMPLEXES; MUSCLE PROTEINS; MYOCYTES, CARDIAC;

EID: 84937684211     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.304937     Document Type: Review

References (160)

1. Gautel M., The sarcomeric cytoskeleton: who picks up the strain? Curr Opin Cell Biol 2011; 23: 39-46. doi: 10.1016/j.ceb.2010.12.001.
2. Spudich JA., The myosin swinging cross-bridge model. Nat Rev Mol Cell Biol 2001; 2: 387-392.
3. Buyandelger B, Mansfield C, Knöll R., Mechano-signaling in heart failure. Pflugers Arch 2014; 466: 1093-1099. doi: 10.1007/s00424-014-1468-4
4. Frank D, Frey N., Cardiac Z-disc signaling network. J Biol Chem 2011; 286: 9897-9904. doi: 10.1074/jbc.R110.174268
5. Tangney JR, Chuang JS, Janssen MS, Krishnamurthy A, Liao P, Hoshijima M, Wu X, Meininger GA, Muthuchamy M, Zemljic-Harpf A, Ross RS, Frank LR, McCulloch AD, Omens JH., Novel role for vinculin in ventricular myocyte mechanics and dysfunction. Biophys J 2013; 104: 1623-1633. doi: 10.1016/j.bpj.2013.02.021
6. Simpson DG, Majeski M, Borg TK, Terracio L., Regulation of cardiac myocyte protein turnover and myofibrillar structure in vitro by specific directions of stretch. Circ Res 1999 85 e59 e69
7. Gopalan SM, Flaim C, Bhatia SN, Hoshijima M, Knoell R, Chien KR, Omens JH, McCulloch AD., Anisotropic stretch-induced hypertrophy in neonatal ventricular myocytes micropatterned on deformable elastomers. Biotechnol Bioeng 2003; 81: 578-587. doi: 10.1002/bit.10506
8. Kerckhoffs RC, Omens J, McCulloch AD., A single strain-based growth law predicts concentric and eccentric cardiac growth during pressure and volume overload. Mech Res Commun 2012; 42: 40-50. doi: 10.1016/j.mechrescom.2011.11.004
9. Peter AK, Cheng H, Ross RS, Knowlton KU, Chen J., The costamere bridges sarcomeres to the sarcolemma in striated muscle. Prog Pediatr Cardiol 2011; 31: 83-88. doi: 10.1016/j.ppedcard.2011.02.003
10. Lazarides E., Intermediate filaments as mechanical integrators of cellular space. Nature 1980; 283: 249-256.
11. Sheikh F, Ross RS, Chen J., Cell-cell connection to cardiac disease. Trends Cardiovasc Med 2009; 19: 182-190. doi: 10.1016/j.tcm.2009.12.001
12. Prosser BL, Ward CW., Mechano-chemo transduction tunes the heartstrings. Sci Signal 2014 7 pe7. doi: 10.1126/scisignal.2005214
13. Abramochkin DV, Lozinsky IT, Kamkin A., Influence of mechanical stress on fibroblast-myocyte interactions in mammalian heart. J Mol Cell Cardiol 2014; 70: 27-36. doi: 10.1016/j.yjmcc.2013.12.020
14. Reed A, Kohl P, Peyronnet R., Molecular candidates for cardiac stretch-activated ion channels. Glob Cardiol Sci Pract 2014; 2014: 9-25. doi: 10.5339/gcsp.2014.19
15. Anderson BR, Granzier HL., Titin-based tension in the cardiac sarcomere: molecular origin and physiological adaptations. Prog Biophys Mol Biol 2012; 110: 204-217. doi: 10.1016/j.pbiomolbio.2012.08.003
16. Knöll R, Hoshijima M, Hoffman HM, The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 2002; 111: 943-955.
17. Wang K, McClure J, Tu A, Titin: major myofibrillar components of striated muscle. Proc Natl Acad Sci U S A 1979; 76: 3698-3702.
18. Linke WA, Krüger M., The giant protein titin as an integrator of myocyte signaling pathways. Physiology (Bethesda) 2010; 25: 186-198. doi: 10.1152/physiol.00005.2010
19. Granzier HL, Labeit S., The giant protein titin: a major player in myocardial mechanics, signaling, and disease. Circ Res 2004; 94: 284-295. doi: 10.1161/01.RES.0000117769.88862.F8
20. Krüger M, Linke WA., Titin-based mechanical signalling in normal and failing myocardium. J Mol Cell Cardiol 2009; 46: 490-498.
21. Tskhovrebova L, Trinick J., Titin: properties and family relationships. Nat Rev Mol Cell Biol 2003; 4: 679-689. doi: 10.1038/nrm1198
22. Hoshijima M., Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures. Am J Physiol Heart Circ Physiol 2006 290 H1313 H1325. doi: 10.1152/ajpheart.00816.2005
23. Arber S, Halder G, Caroni P., Muscle LIM protein, a novel essential regulator of myogenesis, promotes myogenic differentiation. Cell 1994; 79: 221-231.
24. Heineke J, Ruetten H, Willenbockel C, Gross SC, Naguib M, Schaefer A, Kempf T, Hilfiker-Kleiner D, Caroni P, Kraft T, Kaiser RA, Molkentin JD, Drexler H, Wollert KC., Attenuation of cardiac remodeling after myocardial infarction by muscle LIM protein-calcineurin signaling at the sarcomeric Z-disc. Proc Natl Acad Sci U S A 2005; 102: 1655-1660. doi: 10.1073/pnas.0405488102
25. Arber S, Hunter JJ, Ross J Jr, Hongo M, Sansig G, Borg J, Perriard JC, Chien KR, Caroni P., MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 1997; 88: 393-403.
26. Knöll R, Kostin S, Klede S, A common MLP (muscle LIM protein) variant is associated with cardiomyopathy. Circ Res 2010; 106: 695-704. doi: 10.1161/CIRCRESAHA.109.206243
27. Chang DF, Belaguli NS, Iyer D, Roberts WB, Wu SP, Dong XR, Marx JG, Moore MS, Beckerle MC, Majesky MW, Schwartz RJ., Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev Cell 2003; 4: 107-118.
28. Furukawa T, Ono Y, Tsuchiya H, Katayama Y, Bang ML, Labeit D, Labeit S, Inagaki N, Gregorio CC., Specific interaction of the potassium channel beta-subunit minK with the sarcomeric protein T-cap suggests a T-tubule-myofibril linking system. J Mol Biol 2001; 313: 775-784. doi: 10.1006/jmbi.2001.5053
29. Geier C, Gehmlich K, Ehler E, Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy. Hum Mol Genet 2008; 17: 2753-2765. doi: 10.1093/hmg/ddn160
30. Bertz M, Wilmanns M, Rief M., The titin-telethonin complex is a directed, superstable molecular bond in the muscle Z-disk. Proc Natl Acad Sci U S A 2009; 106: 13307-13310. doi: 10.1073/pnas.0902312106
31. Miller MK, Bang ML, Witt CC, Labeit D, Trombitas C, Watanabe K, Granzier H, McElhinny AS, Gregorio CC, Labeit S., The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules. J Mol Biol 2003; 333: 951-964.
32. Jeyaseelan R, Poizat C, Baker RK, Abdishoo S, Isterabadi LB, Lyons GE, Kedes L., A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. J Biol Chem 1997; 272: 22800-22808.
33. Barash IA, Mathew L, Ryan AF, Chen J, Lieber RL., Rapid muscle-specific gene expression changes after a single bout of eccentric contractions in the mouse. Am J Physiol Cell Physiol 2004 286 C355 C364. doi: 10.1152/ajpcell.00211.2003
34. Torrado M, López E, Centeno A, Castro-Beiras A, Mikhailov AT., Left-right asymmetric ventricular expression of CARP in the piglet heart: regional response to experimental heart failure. Eur J Heart Fail 2004; 6: 161-172. doi: 10.1016/j.ejheart.2003.11.004
35. Zolk O, Frohme M, Maurer A, Kluxen FW, Hentsch B, Zubakov D, Hoheisel JD, Zucker IH, Pepe S, Eschenhagen T., Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochem Biophys Res Commun 2002; 293: 1377-1382. doi: 10.1016/S0006-291X(02)00387-X
36. Aihara Y, Kurabayashi M, Saito Y, Ohyama Y, Tanaka T, Takeda S, Tomaru K, Sekiguchi K, Arai M, Nakamura T, Nagai R., Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter. Hypertension 2000; 36: 48-53.
37. Arimura T, Bos JM, Sato A, Kubo T, Okamoto H, Nishi H, Harada H, Koga Y, Moulik M, Doi YL, Towbin JA, Ackerman MJ, Kimura A., Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy. J Am Coll Cardiol 2009; 54: 334-342. doi: 10.1016/j.jacc.2008.12.082
38. Duboscq-Bidot L, Charron P, Ruppert V, Fauchier L, Richter A, Tavazzi L, Arbustini E, Wichter T, Maisch B, Komajda M, Isnard R, Villard E, EUROGENE Heart Failure Network Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy. Eur Heart J 2009; 30: 2128-2136. doi: 10.1093/eurheartj/ehp225
39. Moulik M, Vatta M, Witt SH, Arola AM, Murphy RT, McKenna WJ, Boriek AM, Oka K, Labeit S, Bowles NE, Arimura T, Kimura A, Towbin JA., ANKRD1, the gene encoding cardiac ankyrin repeat protein, is a novel dilated cardiomyopathy gene. J Am Coll Cardiol 2009; 54: 325-333. doi: 10.1016/j.jacc.2009.02.076
40. Bang ML, Gu Y, Dalton ND, Peterson KL, Chien KR, Chen J., The muscle ankyrin repeat proteins CARP, Ankrd2, and DARP are not essential for normal cardiac development and function at basal conditions and in response to pressure overload. PLoS One 2014 9 e93638. doi: 10.1371/journal.pone.0093638
41. Lun AS, Chen J, Lange S., Probing muscle ankyrin-repeat protein (MARP) structure and function. Anat Rec (Hoboken) 2014; 297: 1615-1629. doi: 10.1002/ar.22968
42. Linke WA, Rudy DE, Centner T, Gautel M, Witt C, Labeit S, Gregorio CC., I-band titin in cardiac muscle is a three-element molecular spring and is critical for maintaining thin filament structure. J Cell Biol 1999; 146: 631-644.
43. Sheikh F, Raskin A, Chu PH, An FHL1-containing complex within the cardiomyocyte sarcomere mediates hypertrophic biomechanical stress responses in mice. J Clin Invest 2008; 118: 3870-3880. doi: 10.1172/JCI34472
44. Chu PH, Ruiz-Lozano P, Zhou Q, Cai C, Chen J., Expression patterns of FHL/SLIM family members suggest important functional roles in skeletal muscle and cardiovascular system. Mech Dev 2000; 95: 259-265.
45. Gaussin V, Tomlinson JE, Depre C, Engelhardt S, Antos CL, Takagi G, Hein L, Topper JN, Liggett SB, Olson EN, Lohse MJ, Vatner SF, Vatner DE., Common genomic response in different mouse models of beta-adrenergic-induced cardiomyopathy. Circulation 2003; 108: 2926-2933. doi: 10.1161/01.CIR.0000101922.18151.7B
46. Hwang DM, Dempsey AA, Wang RX, A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes. Circulation 1997; 96: 4146-4203.
47. Hwang DM, Dempsey AA, Lee CY, Liew CC., Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags. Genomics 2000; 66: 1-14. doi: 10.1006/geno.2000.6171
48. Lim DS, Roberts R, Marian AJ., Expression profiling of cardiac genes in human hypertrophic cardiomyopathy: insight into the pathogenesis of phenotypes. J Am Coll Cardiol 2001; 38: 1175-1180.
49. Wettschureck N, Rütten H, Zywietz A, Gehring D, Wilkie TM, Chen J, Chien KR, Offermanns S., Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes. Nat Med 2001; 7: 1236-1240. doi: 10.1038/nm1101-1236
50. Christodoulou DC, Wakimoto H, Onoue K, 5'RNA-Seq identifies Fhl1 as a genetic modifier in cardiomyopathy. J Clin Invest 2014; 124: 1364-1370. doi: 10.1172/JCI70108
51. Raskin A, Lange S, Banares K, Lyon RC, Zieseniss A, Lee LK, Yamazaki KG, Granzier HL, Gregorio CC, McCulloch AD, Omens JH, Sheikh F., A novel mechanism involving four-and-a-half LIM domain protein-1 and extracellular signal-regulated kinase-2 regulates titin phosphorylation and mechanics. J Biol Chem 2012; 287: 29273-29284. doi: 10.1074/jbc.M112.372839
52. Obermann WM, Gautel M, Steiner F, van der Ven PF, Weber K, Fürst DO., The structure of the sarcomeric M band: localization of defined domains of myomesin, M-protein, and the 250-kD carboxy-terminal region of titin by immunoelectron microscopy. J Cell Biol 1996; 134: 1441-1453.
53. Gautel M., Cytoskeletal protein kinases: titin and its relations in mechanosensing. Pflugers Arch 2011; 462: 119-134. doi: 10.1007/s00424-011-0946-1
54. Puchner EM, Alexandrovich A, Kho AL, Hensen U, Schäfer LV, Brandmeier B, Gräter F, Grubmüller H, Gaub HE, Gautel M., Mechanoenzymatics of titin kinase. Proc Natl Acad Sci U S A 2008; 105: 13385-13390. doi: 10.1073/pnas.0805034105
55. Lange S, Xiang F, Yakovenko A, The kinase domain of titin controls muscle gene expression and protein turnover. Science 2005; 308: 1599-1603. doi: 10.1126/science.1110463
56. Bogomolovas J, Gasch A, Simkovic F, Rigden DJ, Labeit S, Mayans O., Titin kinase is an inactive pseudokinase scaffold that supports MuRF1 recruitment to the sarcomeric M-line. Open Biol 2014 4 140041. doi: 10.1098/rsob.140041
57. Witt CC, Witt SH, Lerche S, Labeit D, Back W, Labeit S., Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. EMBO J 2008; 27: 350-360. doi: 10.1038/sj.emboj.7601952
58. Lyon RC, Lange S, Sheikh F., Breaking down protein degradation mechanisms in cardiac muscle. Trends Mol Med 2013; 19: 239-249. doi: 10.1016/j.molmed.2013.01.005
59. Johansen T, Lamark T., Selective autophagy mediated by autophagic adapter proteins. Autophagy 2011; 7: 279-296.
60. Backues SK, Klionsky DJ., Autophagy gets in on the regulatory act. J Mol Cell Biol 2011; 3: 76-77. doi: 10.1093/jmcb/mjq033
61. Edström L, Thornell LE, Albo J, Landin S, Samuelsson M., Myopathy with respiratory failure and typical myofibrillar lesions. J Neurol Sci 1990; 96: 211-228.
62. Hedberg C, Melberg A, Dahlbom K, Oldfors A., Hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain. Brain 2014 137 e270. doi: 10.1093/brain/awt305
63. Lange S, Edström L, Udd B, Gautel M., Reply: Hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain. Brain 2014 137 e279. doi: 10.1093/brain/awu033
64. Pfeffer G, Griffin H, Pyle A, Horvath R, Chinnery PF., Reply: hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain. Brain 2014 137 e271. doi: 10.1093/brain/awt306
65. Pfeffer G, Chinnery PF., Reply: hereditary myopathy with early respiratory failure is caused by mutations in the titin FN3 119 domain. Brain 2014 137 e280. doi: 10.1093/brain/awu034
66. Chauveau C, Bonnemann CG, Julien C, Recessive TTN truncating mutations define novel forms of core myopathy with heart disease. Hum Mol Genet 2014; 23: 980-991. doi: 10.1093/hmg/ddt494
67. Crabtree GR, Olson EN., NFAT signaling: choreographing the social lives of cells. Cell 2002 109 S67 S79
68. Frank D, Kuhn C, Katus HA, Frey N., The sarcomeric Z-disc: a nodal point in signalling and disease. J Mol Med (Berl) 2006; 84: 446-468. doi: 10.1007/s00109-005-0033-1
69. Jeong D, Kim JM, Cha H, Oh JG, Park J, Yun SH, Ju ES, Jeon ES, Hajjar RJ, Park WJ., PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling. Circ Res 2008; 102: 711-719. doi: 10.1161/CIRCRESAHA.107.165985
70. Frey N, Barrientos T, Shelton JM, Frank D, Rütten H, Gehring D, Kuhn C, Lutz M, Rothermel B, Bassel-Duby R, Richardson JA, Katus HA, Hill JA, Olson EN., Mice lacking calsarcin-1 are sensitized to calcineurin signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress. Nat Med 2004; 10: 1336-1343. doi: 10.1038/nm1132
71. Osio A, Tan L, Chen SN, Lombardi R, Nagueh SF, Shete S, Roberts R, Willerson JT, Marian AJ., Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy. Circ Res 2007; 100: 766-768. doi: 10.1161/01.RES.0000263008.66799.aa
72. Yoshida M, Sho E, Nanjo H, Takahashi M, Kobayashi M, Kawamura K, Honma M, Komatsu M, Sugita A, Yamauchi M, Hosoi T, Ito Y, Masuda H., Weaving hypothesis of cardiomyocyte sarcomeres: discovery of periodic broadening and narrowing of intercalated disk during volume-load change. Am J Pathol 2010; 176: 660-678. doi: 10.2353/ajpath.2010.090348
73. Mezzano V, Sheikh F., Cell-cell junction remodeling in the heart: possible role in cardiac conduction system function and arrhythmias? Life Sci 2012; 90: 313-321. doi: 10.1016/j.lfs.2011.12.009
74. Michaelson JE, Huang H., Cell-cell junctional proteins in cardiovascular mechanotransduction. Ann Biomed Eng 2012; 40: 568-577. doi: 10.1007/s10439-011-0439-6
75. Nagafuchi A., Molecular architecture of adherens junctions. Curr Opin Cell Biol 2001; 13: 600-603.
76. Chopra A, Tabdanov E, Patel H, Janmey PA, Kresh JY., Cardiac myocyte remodeling mediated by N-cadherin-dependent mechanosensing. Am J Physiol Heart Circ Physiol 2011 300 H1252 H1266. doi: 10.1152/ajpheart.00515.2010
77. Kostetskii I, Li J, Xiong Y, Zhou R, Ferrari VA, Patel VV, Molkentin JD, Radice GL., Induced deletion of the N-cadherin gene in the heart leads to dissolution of the intercalated disc structure. Circ Res 2005; 96: 346-354. doi: 10.1161/01.RES.0000156274.72390.2c
78. Rimm DL, Koslov ER, Kebriaei P, Cianci CD, Morrow JS., Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc Natl Acad Sci U S A 1995; 92: 8813-8817.
79. Yonemura S, Wada Y, Watanabe T, Nagafuchi A, Shibata M., alpha-Catenin as a tension transducer that induces adherens junction development. Nat Cell Biol 2010; 12: 533-542. doi: 10.1038/ncb2055
80. Sheikh F, Chen Y, Chen Y, Liang X, Hirschy A, Stenbit AE, Gu Y, Dalton ND, Yajima T, Lu Y, Knowlton KU, Peterson KL, Perriard JC, Chen J., alpha-E-catenin inactivation disrupts the cardiomyocyte adherens junction, resulting in cardiomyopathy and susceptibility to wall rupture. Circulation 2006; 114: 1046-1055. doi: 10.1161/CIRCULATIONAHA.106.634469
81. van den Borne SW, Narula J, Voncken JW, Lijnen PM, Vervoort-Peters HT, Dahlmans VE, Smits JF, Daemen MJ, Blankesteijn WM., Defective intercellular adhesion complex in myocardium predisposes to infarct rupture in humans. J Am Coll Cardiol 2008; 51: 2184-2192. doi: 10.1016/j.jacc.2008.02.056
82. Zemljic-Harpf AE, Ponrartana S, Avalos RT, Jordan MC, Roos KP, Dalton ND, Phan VQ, Adamson ED, Ross RS., Heterozygous inactivation of the vinculin gene predisposes to stress-induced cardiomyopathy. Am J Pathol 2004; 165: 1033-1044. doi: 10.1016/S0002-9440(10)63364-0
83. Zemljic-Harpf AE, Miller JC, Henderson SA, Wright AT, Manso AM, Elsherif L, Dalton ND, Thor AK, Perkins GA, McCulloch AD, Ross RS., Cardiac-myocyte-specific excision of the vinculin gene disrupts cellular junctions, causing sudden death or dilated cardiomyopathy. Mol Cell Biol 2007; 27: 7522-7537. doi: 10.1128/MCB.00728-07
84. Olson TM, Illenberger S, Kishimoto NY, Huttelmaier S, Keating MT, Jockusch BM., Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 2002; 105: 431-437.
85. Ehler E, Horowits R, Zuppinger C, Price RL, Perriard E, Leu M, Caroni P, Sussman M, Eppenberger HM, Perriard JC., Alterations at the intercalated disk associated with the absence of muscle LIM protein. J Cell Biol 2001; 153: 763-772.
86. Zhang JQ, Elzey B, Williams G, Lu S, Law DJ, Horowits R., Ultrastructural and biochemical localization of N-RAP at the interface between myofibrils and intercalated disks in the mouse heart. Biochemistry 2001; 40: 14898-14906.
87. Pieperhoff S, Franke WW., The area composita of adhering junctions connecting heart muscle cells of vertebrates-IV: coalescence and amalgamation of desmosomal and adhaerens junction components-late processes in mammalian heart development. Eur J Cell Biol 2007; 86: 377-391. doi: 10.1016/j.ejcb.2007.04.001
88. James CA, Calkins H., Update on Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C). Curr Treat Options Cardiovasc Med 2013; 15: 476-487. doi: 10.1007/s11936-013-0251-8
89. Taylor M, Graw S, Sinagra G, Genetic variation in titin in arrhythmogenic right ventricular cardiomyopathy-overlap syndromes. Circulation 2011; 124: 876-885. doi: 10.1161/CIRCULATIONAHA.110.005405
90. Bennett PM, Maggs AM, Baines AJ, Pinder JC., The transitional junction: a new functional subcellular domain at the intercalated disc. Mol Biol Cell 2006; 17: 2091-2100. doi: 10.1091/mbc.E05-12-1109
91. Marcus FI, Edson S, Towbin JA., Genetics of arrhythmogenic right ventricular cardiomyopathy: a practical guide for physicians. J Am Coll Cardiol 2013; 61: 1945-1948. doi: 10.1016/j.jacc.2013.01.073
92. Pilichou K, Nava A, Basso C, Beffagna G, Bauce B, Lorenzon A, Frigo G, Vettori A, Valente M, Towbin J, Thiene G, Danieli GA, Rampazzo A., Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. Circulation 2006; 113: 1171-1179. doi: 10.1161/CIRCULATIONAHA.105.583674
93. Pilichou K, Remme CA, Basso C, Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy. J Exp Med 2009; 206: 1787-1802. doi: 10.1084/jem.20090641
94. Krusche CA, Holthöfer B, Hofe V, van de Sandt AM, Eshkind L, Bockamp E, Merx MW, Kant S, Windoffer R, Leube RE., Desmoglein 2 mutant mice develop cardiac fibrosis and dilation. Basic Res Cardiol 2011; 106: 617-633. doi: 10.1007/s00395-011-0175-y
95. Kant S, Krull P, Eisner S, Leube RE, Krusche CA., Histological and ultrastructural abnormalities in murine desmoglein 2-mutant hearts. Cell Tissue Res 2012; 348: 249-259. doi: 10.1007/s00441-011-1322-3
96. Garcia-Gras E, Lombardi R, Giocondo MJ, Willerson JT, Schneider MD, Khoury DS, Marian AJ., Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy. J Clin Invest 2006; 116: 2012-2021. doi: 10.1172/JCI27751
97. Yang Z, Bowles NE, Scherer SE, Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Res 2006; 99: 646-655. doi: 10.1161/01.RES.0000241482.19382.c6
98. Lyon RC, Mezzano V, Wright AT, Connexin defects underlie arrhythmogenic right ventricular cardiomyopathy in a novel mouse model. Hum Mol Genet 2014; 23: 1134-1150. doi: 10.1093/hmg/ddt508
99. Uzumcu A, Norgett EE, Dindar A, Uyguner O, Nisli K, Kayserili H, Sahin SE, Dupont E, Severs NJ, Leigh IM, Yuksel-Apak M, Kelsell DP, Wollnik B., Loss of desmoplakin isoform I causes early onset cardiomyopathy and heart failure in a Naxos-like syndrome. J Med Genet 2006 43 e5. doi: 10.1136/jmg.2005.032904
100. Lombardi R, Marian AJ., Arrhythmogenic right ventricular cardiomyopathy is a disease of cardiac stem cells. Curr Opin Cardiol 2010; 25: 222-228. doi: 10.1097/HCO.0b013e3283376daf
101. Asimaki A, Tandri H, Huang H, Halushka MK, Gautam S, Basso C, Thiene G, Tsatsopoulou A, Protonotarios N, McKenna WJ, Calkins H, Saffitz JE., A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy. N Engl J Med 2009; 360: 1075-1084. doi: 10.1056/NEJMoa0808138
102. Lombardi R, da Graca Cabreira-Hansen M, Bell A, Fromm RR, Willerson JT, Marian AJ., Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy. Circ Res 2011; 109: 1342-1353. doi: 10.1161/CIRCRESAHA.111.255075
103. Chen SN, Gurha P, Lombardi R, Ruggiero A, Willerson JT, Marian AJ., The hippo pathway is activated and is a causal mechanism for adipogenesis in arrhythmogenic cardiomyopathy. Circ Res 2014; 114: 454-468. doi: 10.1161/CIRCRESAHA.114.302810
104. Hariharan V, Asimaki A, Michaelson JE, Plovie E, MacRae CA, Saffitz JE, Huang H., Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion. Cardiovasc Res 2014; 104: 280-289. doi: 10.1093/cvr/cvu212
105. Asimaki A, Kapoor S, Plovie E, Karin Arndt A, Adams E, Liu Z, James CA, Judge DP, Calkins H, Churko J, Wu JC, MacRae CA, Kléber AG, Saffitz JE., Identification of a new modulator of the intercalated disc in a zebrafish model of arrhythmogenic cardiomyopathy. Sci Transl Med 2014 6 240ra74. doi: 10.1126/scitranslmed.3008008
106. Kirchhof P, Fabritz L, Zwiener M, Witt H, Schäfers M, Zellerhoff S, Paul M, Athai T, Hiller KH, Baba HA, Breithardt G, Ruiz P, Wichter T, Levkau B., Age-and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 2006; 114: 1799-1806. doi: 10.1161/CIRCULATIONAHA.106.624502
107. Fabritz L, Hoogendijk MG, Scicluna BP, Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice. J Am Coll Cardiol 2011; 57: 740-750. doi: 10.1016/j.jacc.2010.09.046
108. Li D, Liu Y, Maruyama M, Zhu W, Chen H, Zhang W, Reuter S, Lin SF, Haneline LS, Field LJ, Chen PS, Shou W., Restrictive loss of plakoglobin in cardiomyocytes leads to arrhythmogenic cardiomyopathy. Hum Mol Genet 2011; 20: 4582-4596. doi: 10.1093/hmg/ddr392
109. Li J, Swope D, Raess N, Cheng L, Muller EJ, Radice GL., Cardiac tissue-restricted deletion of plakoglobin results in progressive cardiomyopathy and activation of {beta}-catenin signaling. Mol Cell Biol 2011; 31: 1134-1144. doi: 10.1128/MCB.01025-10
110. Swope D, Cheng L, Gao E, Li J, Radice GL., Loss of cadherin-binding proteins β-catenin and plakoglobin in the heart leads to gap junction remodeling and arrhythmogenesis. Mol Cell Biol 2012; 32: 1056-1067. doi: 10.1128/MCB.06188-11
111. Lodder EM, Rizzo S., Mouse models in arrhythmogenic right ventricular cardiomyopathy. Front Physiol 2012 3 221. doi: 10.3389/fphys.2012.00221
112. Li Z, Colucci-Guyon E, Pinçon-Raymond M, Mericskay M, Pournin S, Paulin D, Babinet C., Cardiovascular lesions and skeletal myopathy in mice lacking desmin. Dev Biol 1996; 175: 362-366. doi: 10.1006/dbio.1996.0122
113. Thornell L, Carlsson L, Li Z, Mericskay M, Paulin D., Null mutation in the desmin gene gives rise to a cardiomyopathy. J Mol Cell Cardiol 1997; 29: 2107-2124.
114. Milner DJ, Taffet GE, Wang X, Pham T, Tamura T, Hartley C, Gerdes AM, Capetanaki Y., The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function. J Mol Cell Cardiol 1999; 31: 2063-2076.
115. Goldfarb LG, Park KY, Cervenáková L, Gorokhova S, Lee HS, Vasconcelos O, Nagle JW, Semino-Mora C, Sivakumar K, Dalakas MC., Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 1998; 19: 402-403. doi: 10.1038/1300
116. Klauke B, Kossmann S, Gaertner A, Brand K, Stork I, Brodehl A, Dieding M, Walhorn V, Anselmetti D, Gerdes D, Bohms B, Schulz U, Zu Knyphausen E, Vorgerd M, Gummert J, Milting H., De novo desmin-mutation N116S is associated with arrhythmogenic right ventricular cardiomyopathy. Hum Mol Gene 2010; 19: 4595-4607. doi: 10.1093/hmg/ddq387
117. Kreplak L, Bär H., Severe myopathy mutations modify the nanomechanics of desmin intermediate filaments. J Mol Biol 2009; 385: 1043-1051. doi: 10.1016/j.jmb.2008.10.095
118. Danowski BA, Imanaka-Yoshida K, Sanger JM, Sanger JW., Costameres are sites of force transmission to the substratum in adult rat cardiomyocytes. J Cell Biol 1992; 118: 1411-1420.
119. Manso AM, Li R, Monkley SJ, Cruz NM, Ong S, Lao DH, Koshman YE, Gu Y, Peterson KL, Chen J, Abel ED, Samarel AM, Critchley DR, Ross RS., Talin1 has unique expression versus talin 2 in the heart and modifies the hypertrophic response to pressure overload. J Biol Chem 2013; 288: 4252-4264. doi: 10.1074/jbc.M112.427484
120. Sharp WW, Simpson DG, Borg TK, Samarel AM, Terracio L., Mechanical forces regulate focal adhesion and costamere assembly in cardiac myocytes. Am J Physiol 1997 273 H546 H556
121. Kostin S, Scholz D, Shimada T, Maeno Y, Mollnau H, Hein S, Schaper J., The internal and external protein scaffold of the T-tubular system in cardiomyocytes. Cell Tissue Res 1998; 294: 449-460.
122. Imanaka-Yoshida K, Enomoto-Iwamoto M, Yoshida T, Sakakura T., Vinculin, Talin, Integrin alpha6beta1 and laminin can serve as components of attachment complex mediating contraction force transmission from cardiomyocytes to extracellular matrix. Cell Motil Cytoskeleton 1999; 42: 1-11. doi: 10.1002/(SICI)1097-0169(1999)42:1<1::AID-CM1>3.0.CO;2-0
123. Carter WG, Wayner EA, Bouchard TS, Kaur P., The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells. J Cell Biol 1990; 110: 1387-1404.
124. Israeli-Rosenberg S, Manso AM, Okada H, Ross RS., Integrins and integrin-associated proteins in the cardiac myocyte. Circ Res 2014; 114: 572-586. doi: 10.1161/CIRCRESAHA.114.301275
125. Nawata J, Ohno I, Isoyama S, Suzuki J, Miura S, Ikeda J, Shirato K., Differential expression of alpha 1, alpha 3 and alpha 5 integrin subunits in acute and chronic stages of myocardial infarction in rats. Cardiovasc Res 1999; 43: 371-381.
126. Babbitt CJ, Shai SY, Harpf AE, Pham CG, Ross RS., Modulation of integrins and integrin signaling molecules in the pressure-loaded murine ventricle. Histochem Cell Biol 2002; 118: 431-439. doi: 10.1007/s00418-002-0476-1
127. Shai SY, Harpf AE, Babbitt CJ, Jordan MC, Fishbein MC, Chen J, Omura M, Leil TA, Becker KD, Jiang M, Smith DJ, Cherry SR, Loftus JC, Ross RS., Cardiac myocyte-specific excision of the beta1 integrin gene results in myocardial fibrosis and cardiac failure. Circ Res 2002; 90: 458-464.
128. Li R, Wu Y, Manso AM, Gu Y, Liao P, Israeli S, Yajima T, Nguyen U, Huang MS, Dalton ND, Peterson KL, Ross RS., β1 integrin gene excision in the adult murine cardiac myocyte causes defective mechanical and signaling responses. Am J Pathol 2012; 180: 952-962. doi: 10.1016/j.ajpath.2011.12.007
129. Knöll R, Postel R, Wang J, Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in cardiomyocytes and endothelial cells. Circulation 2007; 116: 515-525. doi: 10.1161/CIRCULATIONAHA.107.689984
130. Lu H, Fedak PW, Dai X, Du C, Zhou YQ, Henkelman M, Mongroo PS, Lau A, Yamabi H, Hinek A, Husain M, Hannigan G, Coles JG., Integrin-linked kinase expression is elevated in human cardiac hypertrophy and induces hypertrophy in transgenic mice. Circulation 2006; 114: 2271-2279. doi: 10.1161/CIRCULATIONAHA.106.642330
131. White DE, Coutu P, Shi YF, Tardif JC, Nattel S, St Arnaud R, Dedhar S, Muller WJ., Targeted ablation of ILK from the murine heart results in dilated cardiomyopathy and spontaneous heart failure. Genes Dev 2006; 20: 2355-2360. doi: 10.1101/gad.1458906
132. Traister A, Li M, Aafaqi S, Integrin-linked kinase mediates force transduction in cardiomyocytes by modulating SERCA2a/PLN function. Nat Commun 2014 5 4533. doi: 10.1038/ncomms5533
133. Zemljic-Harpf A, Manso AM, Ross RS., Vinculin and talin: focus on the myocardium. J Investig Med 2009; 57: 849-855. doi: 10.231/JIM.0b013e3181c5e074
134. Xu W, Baribault H, Adamson ED., Vinculin knockout results in heart and brain defects during embryonic development. Development 1998; 125: 327-337.
135. Critchley DR., Biochemical and structural properties of the integrin-associated cytoskeletal protein talin. Annu Rev Biophys 2009; 38: 235-254. doi: 10.1146/annurev.biophys.050708.133744
136. Pham CG, Harpf AE, Keller RS, Vu HT, Shai SY, Loftus JC, Ross RS., Striated muscle-specific beta(1D)-integrin and FAK are involved in cardiac myocyte hypertrophic response pathway. Am J Physiol Heart Circ Physiol 2000 279 H2916 H2926
137. Kovacic-Milivojević B, Roediger F, Almeida EA, Damsky CH, Gardner DG, Ilić D., Focal adhesion kinase and p130Cas mediate both sarcomeric organization and activation of genes associated with cardiac myocyte hypertrophy. Mol Biol Cell 2001; 12: 2290-2307.
138. Kovacic-Milivojević B, Damsky CC, Gardner DG, Ilić D., Requirements for the localization of p130 Cas to Z-lines in cardiac myocytes. Cell Mol Biol Lett 2002; 7: 323-329.
139. Durieux AC, D'Antona G, Desplanches D, Freyssenet D, Klossner S, Bottinelli R, Flück M., Focal adhesion kinase is a load-dependent governor of the slow contractile and oxidative muscle phenotype. J Physiol 2009; 587: 3703-3717. doi: 10.1113/jphysiol.2009.171355
140. Israeli-Rosenberg S, Chen C, Li R, Deussen DN, Niesman IR, Okada H, Patel HH, Roth DM, Ross RS., Caveolin modulates integrin function and mechanical activation in the cardiomyocyte. FASEB J 2015; 29: 374-384. doi: 10.1096/fj.13-243139
141. Head BP, Patel HH, Insel PA., Interaction of membrane/lipid rafts with the cytoskeleton: impact on signaling and function: membrane/lipid rafts, mediators of cytoskeletal arrangement and cell signaling. Biochim Biophys Acta 2014; 1838: 532-545. doi: 10.1016/j.bbamem.2013.07.018
142. Chidlow JH Jr, Sessa WC., Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc Res 2010; 86: 219-225. doi: 10.1093/cvr/cvq075
143. Insel PA, Head BP, Patel HH, Roth DM, Bundey RA, Swaney JS., Compartmentation of G-protein-coupled receptors and their signalling components in lipid rafts and caveolae. Biochem Soc Trans 2005; 33: 1131-1134. doi: 10.1042/BST20051131
144. Ervasti JM, Campbell KP., Dystrophin-associated glycoproteins: their possible roles in the pathogenesis of Duchenne muscular dystrophy. Mol Cell Biol Hum Dis Ser 1993; 3: 139-166.
145. Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP., Identification and characterization of the dystrophin anchoring site on beta-dystroglycan. J Biol Chem 1995; 270: 27305-27310.
146. Towbin JA, Hejtmancik JF, Brink P, Gelb B, Zhu XM, Chamberlain JS, McCabe ER, Swift M., X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 1993; 87: 1854-1865.
147. Hoffman EP, Brown RH Jr, Kunkel LM., Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51: 919-928.
148. Elsherif L, Huang MS, Shai SY, Yang Y, Li RY, Chun J, Mekany MA, Chu AL, Kaufman SJ, Ross RS., Combined deficiency of dystrophin and beta1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification. Circ Res 2008; 102: 1109-1117. doi: 10.1161/CIRCRESAHA.108.173153
149. Kirchhof P, Fortmüller L, Waldeyer C, Breithardt G, Fabritz L., Drugs that interact with cardiac electro-mechanics: old and new targets for treatment. Prog Biophys Mol Biol 2008; 97: 497-512. doi: 10.1016/j.pbiomolbio.2008.02.003
150. Yu H, van Berkel TJ, Biessen EA., Therapeutic potential of VIVIT, a selective peptide inhibitor of nuclear factor of activated T cells, in cardiovascular disorders. Cardiovasc Drug Rev 2007; 25: 175-187. doi: 10.1111/j.1527-3466.2007.00011.x
151. Pellicena P, Schulman H., CaMKII inhibitors: from research tools to therapeutic agents. Front Pharmacol 2014 5 21. doi: 10.3389/fphar.2014.00021
152. Molkentin JD., Calcineurin and beyond: cardiac hypertrophic signaling. Circ Res 2000; 87: 731-738.
153. Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF, Molkentin JD., Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science 1998; 281: 1690-1693.
154. Ding B, Price RL, Borg TK, Weinberg EO, Halloran PF, Lorell BH., Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin. Circ Res 1999; 84: 729-734.
155. Zhang W, Kowal RC, Rusnak F, Sikkink RA, Olson EN, Victor RG., Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ Res 1999; 84: 722-728.
156. Luo Z, Shyu KG, Gualberto A, Walsh K., Calcineurin inhibitors and cardiac hypertrophy. Nat Med 1998; 4: 1092-1093. doi: 10.1038/2578
157. Wang X, Culotta VC, Klee CB., Superoxide dismutase protects calcineurin from inactivation. Nature 1996; 383: 434-437. doi: 10.1038/383434a0
158. Mervaala E, Müller DN, Park JK, Dechend R, Schmidt F, Fiebeler A, Bieringer M, Breu V, Ganten D, Haller H, Luft FC., Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes. Hypertension 2000; 35: 360-366.
159. Oie E, Bjørnerheim R, Clausen OP, Attramadal H., Cyclosporin A inhibits cardiac hypertrophy and enhances cardiac dysfunction during postinfarction failure in rats. Am J Physiol Heart Circ Physiol 2000 278 H2115 H2123
160. Mende U, Kagen A, Cohen A, Aramburu J, Schoen FJ, Neer EJ., Transient cardiac expression of constitutively active Galphaq leads to hypertrophy and dilated cardiomyopathy by calcineurin-dependent and independent pathways. Proc Natl Acad Sci U S A 1998; 95: 13893-13898.